Central  ||| S:0 E:8 ||| JJ
blood  ||| S:8 E:14 ||| NN
pressure  ||| S:14 E:23 ||| NN
in  ||| S:23 E:26 ||| IN
chronic  ||| S:26 E:34 ||| JJ
kidney  ||| S:34 E:41 ||| NN
disease ||| S:41 E:48 ||| NN
:  ||| S:48 E:50 ||| :
latest  ||| S:50 E:57 ||| JJS
evidence  ||| S:57 E:66 ||| NN
and  ||| S:66 E:70 ||| CC
clinical  ||| S:70 E:79 ||| JJ
relevance  ||| S:79 E:89 ||| NN
Chronic  ||| S:89 E:97 ||| NNP
kidney  ||| S:97 E:104 ||| NN
disease  ||| S:104 E:112 ||| NN
( ||| S:112 E:113 ||| -LRB-
CKD ||| S:113 E:116 ||| NNP
)  ||| S:116 E:118 ||| -RRB-
has  ||| S:118 E:122 ||| VBZ
been  ||| S:122 E:127 ||| VBN
consistently  ||| S:127 E:140 ||| RB
associated  ||| S:140 E:151 ||| VBN
with  ||| S:151 E:156 ||| IN
cardiovascular  ||| S:156 E:171 ||| JJ
disease ||| S:171 E:178 ||| NN
;  ||| S:178 E:180 ||| :
there  ||| S:180 E:186 ||| EX
is  ||| S:186 E:189 ||| VBZ
an  ||| S:189 E:192 ||| DT
inverse  ||| S:192 E:200 ||| JJ
graded  ||| S:200 E:207 ||| JJ
relationship  ||| S:207 E:220 ||| NN
between  ||| S:220 E:228 ||| IN
glomerular  ||| S:228 E:239 ||| JJ
filtration  ||| S:239 E:250 ||| JJ
rate  ||| S:250 E:255 ||| NN
and  ||| S:255 E:259 ||| CC
cardiovascular  ||| S:259 E:274 ||| JJ
risk ||| S:274 E:278 ||| NN
.  ||| S:278 E:280 ||| .
Early-moderate  ||| S:280 E:295 ||| NNP
CKD  ||| S:295 E:299 ||| NNP
receives  ||| S:299 E:308 ||| VBZ
increasing  ||| S:308 E:319 ||| VBG
recognition  ||| S:319 E:331 ||| NN
for  ||| S:331 E:335 ||| IN
its  ||| S:335 E:339 ||| PRP$
role  ||| S:339 E:344 ||| NN
as  ||| S:344 E:347 ||| IN
an  ||| S:347 E:350 ||| DT
independent  ||| S:350 E:362 ||| JJ
risk  ||| S:362 E:367 ||| NN
factor  ||| S:367 E:374 ||| NN
as  ||| S:374 E:377 ||| IN
evidenced  ||| S:377 E:387 ||| VBN
by  ||| S:387 E:390 ||| IN
its  ||| S:390 E:394 ||| PRP$
recent  ||| S:394 E:401 ||| JJ
inclusion  ||| S:401 E:411 ||| NN
in  ||| S:411 E:414 ||| IN
the  ||| S:414 E:418 ||| DT
Joint  ||| S:418 E:424 ||| NNP
British  ||| S:424 E:432 ||| NNP
Societies ||| S:432 E:441 ||| NNP
'  ||| S:441 E:443 ||| POS
consensus  ||| S:443 E:453 ||| NN
recommendations  ||| S:453 E:469 ||| NNS
for  ||| S:469 E:473 ||| IN
the  ||| S:473 E:477 ||| DT
prevention  ||| S:477 E:488 ||| NN
of  ||| S:488 E:491 ||| IN
cardiovascular  ||| S:491 E:506 ||| JJ
disease ||| S:506 E:513 ||| NN
.  ||| S:513 E:515 ||| .
Data  ||| S:515 E:520 ||| NNS
from  ||| S:520 E:525 ||| IN
both  ||| S:525 E:530 ||| DT
imaging  ||| S:530 E:538 ||| NN
and  ||| S:538 E:542 ||| CC
epidemiological  ||| S:542 E:558 ||| JJ
studies  ||| S:558 E:566 ||| NNS
suggest  ||| S:566 E:574 ||| VBP
arterial  ||| S:574 E:583 ||| JJ
stiffening  ||| S:583 E:594 ||| NN
and  ||| S:594 E:598 ||| CC
structural  ||| S:598 E:609 ||| JJ
left  ||| S:609 E:614 ||| JJ
ventricular  ||| S:614 E:626 ||| JJ
disease  ||| S:626 E:634 ||| NN
( ||| S:634 E:635 ||| -LRB-
hypertrophy  ||| S:635 E:647 ||| NN
and  ||| S:647 E:651 ||| CC
fibrosis ||| S:651 E:659 ||| CD
)  ||| S:659 E:661 ||| -RRB-
are  ||| S:661 E:665 ||| VBP
the  ||| S:665 E:669 ||| DT
key  ||| S:669 E:673 ||| JJ
pathogenic  ||| S:673 E:684 ||| JJ
mediators  ||| S:684 E:694 ||| NNS
of  ||| S:694 E:697 ||| IN
cardiovascular  ||| S:697 E:712 ||| JJ
disease  ||| S:712 E:720 ||| NN
in  ||| S:720 E:723 ||| IN
CKD ||| S:723 E:726 ||| NNP
.  ||| S:726 E:728 ||| .
This  ||| S:728 E:733 ||| DT
review  ||| S:733 E:740 ||| NN
discusses  ||| S:740 E:750 ||| VBD
the  ||| S:750 E:754 ||| DT
rationale  ||| S:754 E:764 ||| NN
for  ||| S:764 E:768 ||| IN
measuring  ||| S:768 E:778 ||| VBG
central  ||| S:778 E:786 ||| JJ
blood  ||| S:786 E:792 ||| NN
pressure  ||| S:792 E:801 ||| NN
in  ||| S:801 E:804 ||| IN
patients  ||| S:804 E:813 ||| NNS
with  ||| S:813 E:818 ||| IN
CKD  ||| S:818 E:822 ||| NNP
and  ||| S:822 E:826 ||| CC
whether  ||| S:826 E:834 ||| IN
it  ||| S:834 E:837 ||| PRP
could  ||| S:837 E:843 ||| MD
provide  ||| S:843 E:851 ||| VB
incremental  ||| S:851 E:863 ||| JJ
prognostic  ||| S:863 E:874 ||| JJ
value  ||| S:874 E:880 ||| NN
beyond  ||| S:880 E:887 ||| IN
that  ||| S:887 E:892 ||| DT
of  ||| S:892 E:895 ||| IN
peripheral  ||| S:895 E:906 ||| JJ
blood  ||| S:906 E:912 ||| NN
pressure ||| S:912 E:920 ||| NN
.  ||| S:920 E:922 ||| .
